netilmicin and Genital-Diseases--Female

In a prospective randomised study 60 patients with gynaecological or intra-abdominal infections were given either 2g iv every 12 hours of cefotetan or a combination of netilmicin (150mg iv every 12 hours) and clindamycin (600mg iv every 8 hours). The clinical condition of nearly half the patients (26 of 60) was characterized as serious and surgical manipulation and drainage were performed in 57 of the 60 patients. The clinical response was similar in both groups with 21 of 29 patients in the cefotetan group and 29 of 33 patients in the netilmicin plus clindamycin group. Side effects were few and mild in nature with no significant differences between the two groups. This work is continuing but the results to date suggest that cefotetan monotherapy is a safe and effective alternative to a combination of netilmicin and clindamycin in the treatment of gynaecological and intra-abdominal infections.

Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefotetan; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Genital Diseases, Female; Humans; Male; Middle Aged; Netilmicin; Prospective Studies; Random Allocation

Topics: Anti-Bacterial Agents; Bacterial Infections; Cefotetan; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Netilmicin; Treatment Outcome